Although the entry of counterfeit products into legitimate pharmaceutical distribution appear to remain limited, there is noticeable growth in trade in bulk products and APIs, according to the latest Brandjacking Index, compiled by MarkMonitor (San Francisco). These products become available […]
Read MoreThe heightened concern over delivering flu vaccines, especially for the H1N1 virus created a dramatic backdrop to this year’s IQPC Cold Chain Distribution for Pharmaceuticals meeting (Philadelphia, Sept. 21-24). Vaccines—one of the larger-volume temperature-sensitive products of biopharma—will be headline news […]
Read MoreWhat if you faced a product launch larger than anything your company had previously undertaken? We faced exactly that with the planned launch of our weight-loss product, alli™ (orlistat). It would be a nationwide effort requiring the distribution of nearly […]
Read MoreAbout five years ago as fee-for-service agreements between manufacturers and wholesalers took hold, wholesalers were able to wring tens of billions of dollars’ worth of working capital from their businesses because they no longer kept excess inventory. Now, according to […]
Read MoreThey are not quantitative measures of actual environmental performance, but they are significantly more than a vanity prize: by two separate scoring indexes, Bristol-Myers Squibb and Roche Holdings lead in this year’s corporate sustainability indices. BMS won the No. 1 […]
Read MoreIt’s no surprise that biopharma faces problems not shared by most other industries who are dealing with the current economic woes; biopharma’s growth was slumping, and its asset base was contracting well before the past year. In a survey and […]
Read MoreThe healthcare-industry business exchange GHX has added its 13th member to a network of supplies and providers called the GHX Health ConneXion data pool. According to the Louisville, CO, company, through GPO members such as Novation, as well as several […]
Read MorePublished annually by the Center for Healthcare Supply Chain Research, the research foundation of HDMA, this year’s Factbook records total sales of $253.3 billion in sales through primary healthcare distributors (essentially, the HDMA membership). That figure is up 5.2% over […]
Read MorePharmaceutical companies are taking big measures to boost sales of newer and brand-name drugs while addressing patient adherence concerns by stepping up “loyalty card” programs. As more insurers and employers switch to pharmacy-benefit plans with tiered formularies to help control […]
Read MoreFullbore, custom research projects are the usual method for developing marketing and commercialization plans, but—in recognition of the tight finances of biopharma today—two market research leaders have announced new ways to tap into their data pools. IMS Health (Norwalk, CT) […]
Read More